Remote Consultation Systems

Ambient Clinical Analytics is a digital health and clinical decision support software company providing FDA Class II and CE Mark-approved solutions for acute care hospitals and health systems. The company specializes in real-time clinical analytics platforms that integrate with existing EHR workflows to reduce alert fatigue, prevent errors, and improve patient outcomes. Primary product lines include Sepsis DART™, an automated sepsis detection and treatment bundle monitoring system; AWARE Clinical Control Tower™, a centralized tele-ICU and clinical command center platform for remote monitoring and collaboration; AWARE Patient Surveillance™ (AWARE Patient View™), providing telehealth and remote patient monitoring via proprietary Clinical Mesh Network™ technology; AWARE Certain™, a clinical intelligence platform for standardized patient evaluation and treatment; and YES Board™, a patient flow management system designed to reduce wait times and length of stay. All platforms leverage clinically vetted rules, indicative and predictive analytics, and smart notifications to guide clinical teams through complex care processes. The company's solutions are designed for deployment across entire health systems and support both centralized and decentralized care models. Ambient markets to hospital administrators, ICU directors, infectious disease specialists, and nursing leadership. Products are commercially deployed in acute care settings and demonstrate compliance with CMS Sepsis-1 reporting requirements. The company emphasizes scientific validation and cost reduction through error prevention and improved care timeliness.

ZiphyCare is a comprehensive telemedicine and remote care platform designed to expand access to high-quality medical care through technology-enabled home health visits and virtual consultations. The company operates a dual model: proprietary software applications and a patented, FDA-registered portable diagnostic kit (ZiphyKit) that enables clinicians to conduct complete physical examinations remotely. ZiphyKit includes hospital-grade devices for blood pressure measurement, pulse oximetry, ECG, digital stethoscopy, and focused visual examinations (eye, ear, throat, wound). The platform integrates with electronic medical records systems in FHIR format for seamless data management. ZiphyCare serves hospitals, medical groups, health plans, and care-at-home organizations. The software suite comprises ZiphyDoc (provider-facing clinical data and decision support), ZiphyStream (remote care with advanced data collection and conferencing), ZiphyApp (patient coordination and care delivery), MyZiphy (patient portal), ZiphyAdmin (operational management), and ZiphyOutreach (scheduling and mass booking). The platform is designed for mobile workflows, automating care coordination, optimizing transitions of care, reducing no-shows and readmissions, and improving HEDIS metrics and STAR Ratings for health plans. ZiphyCare targets underserved populations, including those with technology barriers, health literacy challenges, and limited access to traditional in-person care. The company provides low-cost APIs and integration tools for health technology companies and care delivery organizations seeking to embed telemedicine capabilities.

Visibly is a digital health platform that enables optical retailers, contact lens distributors, and e-commerce vision care companies to deliver comprehensive vision care services remotely and in-store. The company operates an anywhere-care platform providing vision prescription renewals, visual acuity testing, prescription verification, and automated contact lens and eyewear fulfillment. Visibly's VDAP (Vision Digital Assessment Platform) product received FDA clearance in 2022, positioning the company as a clinically validated solution for vision screening and prescription management. The platform leverages a nationwide network of licensed eye care providers to review and renew customer prescriptions within 24 hours. Core offerings include at-home vision screening, in-store vision testing for brick-and-mortar locations, video consultations with licensed eye care providers for non-emergency conditions (dry eyes, pink eye, allergies), and automated prescription verification to ensure Contact Lens Rule compliance. Visibly also provides fulfillment automation through pre-built integrations with leading contact lens distributors, labs, and eyewear manufacturers. The technology is delivered via a modern GraphQL API supporting single integration across all products. Visibly serves major e-commerce and retail vision care customers including Next Day Contacts, EZContacts, LensDirect, and ROKA. The platform is HIPAA-compliant and designed for seamless white-label deployment with branded test experiences and customizable workflows.

SoftLink International is a healthcare IT company headquartered in India, founded in 1997, specializing in software solutions for hospital automation, clinical informatics, patient workflow management, and analytics. The company serves over 450 healthcare institutions across 15 countries, with significant deployments in the USA, Middle East, India, and Far East. Core product offerings include PANACEA (Hospital Information Management System/HIMS), a comprehensive EHR/EMR platform supporting full hospital digitization and paperless operations; Cardiology Solutions (CVIS—Cardiovascular Information System) providing multimodality viewing, cath lab inventory management, and research tools; Radiology Solutions delivering end-to-end PACS (Picture Archiving and Communication Systems) from single clinics to enterprise deployments; and TeleHealth Solutions functioning as standalone or integrated remote consultation platforms. The company maintains compliance certifications including FDA, HIPAA, ISO 9001, ISO 27001, DICOM, HL7, ICD-10, and IHE standards. SoftLink provides custom engineering, system integration, and data migration services. Known strengths include deep EHR/EMR integration experience (compatibility with EPIC, Cerner, and proprietary systems), support for non-DICOM modalities, and agile product innovation. The firm operates on a turnkey model, reducing dependency on third-party vendors. Clientele includes major hospital chains (Apollo, Fortis, Max Healthcare, Mount Sinai), government medical institutions (JIPMER), and specialty centers across multiple disciplines.

MILLENSYS is a healthcare IT and business software company founded in 2008, operating from Cairo, Egypt with offices in Blairstown, New Jersey. The company delivers a unified eHealth platform ecosystem serving 14+ countries and over 49 million patients. MILLENSYS specializes in integrated clinical software solutions including Electronic Health Records (EHR), Hospital Management Information Systems (HMIS), Picture Archiving and Communication Systems (PACS), Laboratory Information Systems (LIS), Radiology Information Systems (RIS), and telemedicine platforms. The company offers enterprise imaging with vendor-neutral archive (VNA) capabilities, cloud-based PACS, teleradiology, and AI-driven diagnostic insights. MILLENSYS also provides commercial software solutions including ERP, CRM, and financial management tools for small-to-medium enterprises. Certified to international standards including IHE/HL7 and DICOM compliance, MILLENSYS serves hospitals, medical centers, clinics, and diagnostic centers with a commitment to seamless data integration, secure cloud management, and optimized operational efficiency.

Rasimo Systems is an FDA-listed integrated health technology company specializing in AI-driven digital therapeutics and remote patient monitoring solutions. The company develops the SureMediks® platform, a comprehensive AI-powered digital health ecosystem designed to manage metabolic risk factors including obesity, diabetes, cardiovascular disease, and MASLD. SureMediks integrates connected medical devices (blood pressure monitors, smart scales, glucose meters, ECG wearables, oximeters, CGM systems, and smart rings) with proprietary "Realistic Intelligence" AI to deliver real-time patient monitoring, personalized treatment pathways, lifestyle interventions, and clinical decision support. The platform connects seamlessly to existing EMR systems via standard APIs and includes customizable dashboards for healthcare providers. Rasimo manufactures FDA-compliant medical devices and offers end-to-end solutions including custom device design, medical software development, EMR integration, and HIPAA-compliant telehealth systems. The company also produces AI-enabled hearing aids (BTE, RIC, ITE styles) and wellness platforms (SureFiz Pro). Serves healthcare providers, pharmaceutical companies, insurers, fitness professionals, and enterprise wellness programs.

HINACOM is a leading healthcare IT software company established in 2008, specializing in medical imaging information systems, telemedicine platforms, and AI-driven diagnostic solutions. The company provides enterprise-grade imaging platforms that integrate with HIS/EMR systems, enabling centralized management of medical imaging data across healthcare networks. Core offerings include PACS systems, regional imaging collaboration platforms, cloud-based digital imaging (e-film) systems, and remote consultation platforms supporting real-time diagnostic consultation, remote training, and multi-party case discussions. HINACOM's proprietary AI algorithms focus on advanced 3D image reconstruction and automated detection (e.g., pulmonary nodule detection) across multiple specialties including ultrasound, endoscopy, ophthalmology, dentistry, nuclear medicine, pathology, and cardiology. The company serves 3,000+ healthcare institutions globally with deployments across China, United States, Europe, Southeast Asia, South Asia, and MENA regions. HINACOM holds regulatory certifications including NMPA, FDA, and CE approvals.

MedWand Solutions is a US-based telehealth device and software company specializing in remote patient examination and vital sign capture. The company manufactures the MedWand Multi-Sensor Device, an FDA 510(k)-cleared hardware platform that enables clinicians to conduct comprehensive physical exams remotely via WiFi or cellular networks. The device captures 10+ clinical-grade biometrics including temperature, blood pressure, oxygen saturation, heart and lung sounds, ECG, otoscope images, and skin imaging. MedWand's VirtualCare Telemedicine Platform integrates with existing EHR and patient management systems through REST API and supports CMS interoperability standards. The platform serves rural clinics, home health, employer on-site programs, substance-use clinics, decentralized clinical trials, and disaster response operations. MedWand emphasizes "treat-in-place" workflows to reduce unnecessary ER transfers and readmissions while lowering healthcare delivery costs. The company offers standalone kiosk deployment options requiring no EHR integration. Third-party Bluetooth device integration allows connection to external blood pressure monitors, glucometers, and weight scales. Key markets include primary care, transitional care, payers seeking HEDIS improvement, and international telehealth expansion (demonstrated operations in Thailand and Rwanda).

Optomed Plc is a Finnish medical technology company specializing in handheld fundus cameras and AI-powered eye-screening solutions. Founded in 2004 and based in Oulu, Optomed develops portable retinal imaging technology for early detection of eye diseases, particularly diabetic retinopathy and related conditions. The company manufactures non-mydriatic fundus cameras including the Smartscope Pro and FDA-cleared Aurora AEYE, integrated with artificial intelligence for enhanced diagnostic accuracy. Optomed's software portfolio—Avenue AI, Avenue Eye Screen, Avenue Flow, and Avenue Telemedicine—enables ophthalmologists, primary care physicians, and pediatricians to manage workflows and conduct remote eye screenings efficiently. The platform supports telemedicine consultations and oculomics analysis for disease monitoring. Optomed serves clinical settings globally through subsidiaries in China and the United States, positioning handheld retinal imaging as accessible screening for diverse patient populations in both primary and specialist care environments.

Mantality Health is a telehealth clinic specializing in personalized hormone optimization and wellness therapies for men and women. The practice offers comprehensive blood analysis (50+ biomarkers) and delivers physician-prescribed, evidence-based treatments including Testosterone Replacement Therapy (TRT), Hormone Replacement Therapy (HRT), Peptide Therapy, and sexual health treatments. All services are delivered remotely via telehealth consultations with at-home lab testing and discreet medication shipment. The company emphasizes precision diagnostics and long-term treatment monitoring rather than generic protocols, positioning itself as part of the Agentis Longevity platform focused on preventive longevity care across the Midwest and Southeast.

LifeBot Inc. develops military-tested telemedicine platforms designed for rugged, mission-critical environments including combat, disaster response, EMS, paramedicine, rural clinics, senior care, and space applications. The company offers a unified telemedicine ecosystem powered by proprietary DREAMS™ OS and ICM™ technologies, enabling hospital-grade clinical capabilities in austere settings. Core product lines include: Link™ (portable field telemedicine unit for vehicles and on-foot deployment), Core™ (crash-cart and ICU hub for emergency departments and field hospitals), Command™ (physician workstation for remote diagnostics and telepresence), and Matrix™ (command hub for fleet oversight and national telehealth coordination). LifeBot's technology integrates physiologic data, audio-visual consultation, and collaborative decision-making workflows to facilitate specialty consultation and accelerate diagnosis and treatment in remote or emergency settings. The company has received multiple awards including Best Portable Telemedicine Award (Frost & Sullivan, 2014), Best Telemedicine Software (Business.com, 2019), and General Maxwell Thurman Award recognition. Deployed with U.S. Army, NASA Human Research Program, Formula 1 medical teams, General Dynamics Land Systems, University of Alberta (Mobile Stroke Unit), and regional EMS systems. The platform demonstrates proven capability in prehospital stroke care, mobile integrated healthcare, and armored vehicle medical support with real-time vital sign transmission and remote physician oversight.

Huma is a UK-based global digital health company providing AI-driven cloud platform solutions for healthcare organizations, pharmaceutical companies, and research institutions. The Huma Cloud Platform (HCP) is a regulated, enterprise-grade infrastructure that enables rapid development and deployment of clinical applications including remote patient monitoring, virtual care, clinical trial data capture, and population health management. The platform integrates analytics, machine learning, and AI agents to transform connected health data into actionable clinical intelligence. Huma's applications span primary care (myGP, eConsult), secondary care (Aluna respiratory, GDm gestational diabetes, eTriage emergency), clinical trials (Alcedis), and public health (population screening, CVD risk assessment). The platform holds regulatory clearances across multiple jurisdictions (FDA 510(k) Class II, MHRA Class IIb, EU MDR, TGA, CDSCO, Saudi FDA, MDSAP) and maintains ISO 13485, ISO 27001, and SOC 2 Type II compliance. Huma supports 100+ applications built by clients, serving 100+ global organizations and approximately 100 million patients. The company's integrated delivery model includes discovery, deployment, and federated scale-up phases for healthcare transformation at national scale.

MEDITECH (Medical Information Technology, Inc.) is a privately held healthcare software company founded in 1969, headquartered in Westwood, Massachusetts. The company specializes in developing and supporting integrated electronic health record (EHR) systems and health information technology solutions for healthcare organizations worldwide. MEDITECH serves approximately 2,400 healthcare sites across the United States, Canada, and the United Kingdom, holding a significant share of the U.S. hospital EHR market. The company's flagship product, MEDITECH Expanse, is a web-based EHR platform featuring cloud deployment, mobile access, point-of-care documentation, patient communication tools, and secure patient health portals. MEDITECH is advancing AI-infused EHR solutions to enhance healthcare delivery, improve physician experience, increase operational efficiency, and support predictive analytics and genomics applications. The platform emphasizes data accessibility and interoperability, enabling healthcare leaders to leverage analytics for performance monitoring, clinicians to make data-driven decisions, and patients to benefit from improved care coordination and engagement. MEDITECH maintains partnerships with major technology firms and continues to evolve its services to meet the diverse needs of health systems ranging from large hospital networks to independent community healthcare organizations.

MouthWatch, Inc. manufactures intraoral cameras and teledentistry software for dental practices, DSOs, academic institutions, and public health settings. The company's primary product line consists of HD intraoral cameras designed for easy-to-use chairside photography that improve patient comprehension, case acceptance, and treatment communication. MouthWatch cameras are deployed in over 46,000 dental practices globally, including major DSOs (Heartland Dental, Pacific Dental Services, Advantage), university dental programs (NYU, Columbia, Roseman), and independent general, pediatric, cosmetic, and mobile dentistry operations. The company's TeleDent software platform enables teledentistry capabilities for private practices, group practices, medical-dental integrated care, public health clinics, dental schools, and mobile dentistry programs. TeleDent facilitates remote patient consultations, photo-based reviews, specialist communication, and patient engagement between in-office visits, supporting continuity of care and practice loyalty. MouthWatch also operates Dentistry.One, a consumer-facing platform enabling direct patient-to-dentist virtual consultations and asynchronous photo review. All cameras are backed by 100% satisfaction guarantees and lifetime free customer support. The company provides continuing education resources, industry webinars, and training materials on intraoral imaging and teledentistry best practices. Regulatory and certification information is not explicitly stated on the provided pages.

Forus Health is a medical technology company founded in 2010 and based in Bengaluru, India, specializing in advanced ophthalmic imaging devices, AI-enabled retinal imaging solutions, and cloud-based telemedicine platforms. The company manufactures a comprehensive range of portable and desktop fundus cameras for adult and neonatal retinal screening, auto-refractometers for refractive assessment, and visual function testing systems. Forus Health's flagship 3nethra product line includes non-mydriatic and mydriatic digital imaging cameras designed for high-resolution retinal diagnostics. The company offers proprietary AI diagnostic solutions (FH-POISE Insights) that detect diabetic retinopathy, glaucoma, age-related macular degeneration, cataract, cardiovascular disease, hypertensive retinopathy, and dry eye conditions. Digital health platforms—FH TeleCare, FH TeleEye, and FH TeleOpticals—enable remote consultation and screening for distributed healthcare delivery. With installations in 75+ countries and impact on over 20 million lives, Forus Health addresses preventable blindness and vision loss, particularly in underserved regions. The company holds CE, FDA 510K, CDSCO, ISO 13485, ISO 27001, and HIPAA certifications.

Nonagon Ltd. designs and distributes FDA-cleared telehealth device kits that enable patients to conduct multiple clinical physical exams remotely via smartphone. The Nonagon Care Kit is a portable, all-in-one diagnostic tool that includes a digital thermometer, stethoscope, pulse oximeter, and otoscope (video ear examination). Patients capture vital signs and visual findings, then securely transmit results to US-certified clinicians for virtual consultation. The platform supports up to nine distinct medical exam types, including temperature, skin photography, oxygen saturation, lung auscultation, cardiac auscultation, otoscopy, abdominal sounds, and throat visualization. Clinical applications span acute care (infections, fever, respiratory conditions including COVID-19, COPD, asthma, pneumonia), dermatology (rashes, cuts, bruises), and ENT (ear infections, sore throat, tonsillitis). Nonagon operates a subscription-based model: ConnectCare membership at $7.99/month provides ongoing result-sharing and clinical access; virtual care visits are priced at $39 (adult) and $49 (pediatric, ages 3–17). The Care Kit retails at $239.99 or $19.99 monthly. Device is FDA-cleared; regulatory clearance substantiates clinical accuracy claims. Target markets include direct-to-consumer telemedicine, family health monitoring, concierge practices, and direct-care clinics seeking to close diagnostic gaps in remote settings.

Aventusoft, LLC is a Boca Raton, Florida-based medical technology company specializing in signal detection analysis and AI-driven digital health platforms since 2010. The company develops innovative solutions focused on cardiac monitoring, clinical decision support, and decentralized clinical research. Primary product lines include Hemotag, a non-invasive cardiac monitoring device paired with AI analytics to reduce reliance on invasive cardiac imaging and implantable devices; CarePear, a digital health platform connecting patients and physicians with US-based sub-specialists through AI-enabled telemedicine; and Trialogy, an AI-driven platform for decentralized clinical trials that streamlines life science research. Aventusoft has received recognition from the NIH (RADx Tech for Maternal Health Challenge), DARPA, American College of Cardiology (ACC Innovation Showcase Award 2021 and 2023), and multiple design and innovation awards. The company demonstrated 146% two-year revenue growth and ranked No. 112 on Inc. Magazine's 2023 Southeast Region fastest-growing private companies list. Products target cardiac care, maternal health, specialist access, and clinical research domains, with regulatory focus on maternal health applications and AI-driven diagnostics.

Thinklabs Medical manufactures digital stethoscopes designed for clinical auscultation and telemedicine integration. The company's flagship product, the Thinklabs One Digital Stethoscope, features 100x audio amplification with five precision filter options, enabling clinicians to isolate and enhance cardiac, pulmonary, and other body sounds. The device includes rechargeable battery technology (100–120 patient exams per charge), Bluetooth and wired connectivity to most headphones and telemedicine platforms, and integrates seamlessly with major EHR and telemedicine software including Zoom, Cisco WebEx, Teladoc, American Well, and other systems without requiring screen switching during patient consultation. The stethoscope is used across 50+ countries and seven continents in primary care, cardiology, pulmonology, nursing, education, critical care, emergency medicine, pediatrics, NICU, anesthesiology, hospice, research, veterinary, and government/military settings. Marketed as a device for both clinical diagnostics and enhanced hearing accessibility for audiologists and hard-of-hearing practitioners, Thinklabs stethoscopes are employed in hospitals, FQHCs, acute care facilities, clinical trials, school-based health programs, and workplace health initiatives. The company emphasizes precision audio engineering and clinical utility without proprietary ecosystems, enabling broad deployment across institutional and private practice settings.

ForaCare Inc. is a healthcare technology company specializing in chronic disease management through integrated medical devices and telehealth software. The company designs and manufactures blood glucose monitors, blood pressure monitors, pulse oximeters, nebulizers, wireless weight scales, and Bluetooth thermometers for diabetes, hypertension, COPD, and chronic heart failure management. All devices connect via cellular or Bluetooth to the proprietary FORA® 24/7 HealthView Telehealth System, a HIPAA-compliant cloud platform that enables real-time remote patient monitoring and physician access to patient data. ForaCare also offers iFORA mobile applications available on iOS and Google Play for patient engagement and chronic disease self-management. The company manufactures and designs products with an emphasis on accuracy, ease of use, and clinical validation. Primary markets include remote patient monitoring programs for chronic disease management across diabetes care, hypertension management, respiratory care, and weight management. The FORA 24/7 HealthView System serves as the central integration hub connecting all wireless medical devices to a telehealth gateway for comprehensive remote monitoring. ForaCare operates with a global customer base and maintains design and manufacturing capabilities.

Escalon Medical Corp. (OTCQB: ESMC) is a publicly-traded medical device company specializing in ophthalmic diagnostics imaging and surgical solutions. Operating through its wholly-owned Sonomed Escalon subsidiary group, the company develops, manufactures, markets, and distributes a portfolio of ophthalmology products including ultrasound imaging systems, digital photography devices, image management platforms, and telemedicine solutions. The Sonomed Escalon brand consolidates products previously marketed under the Sonomed, Escalon Digital Solutions, Escalon, and Trek Medical brands. The company serves ophthalmology practices, surgical centers, and hospitals with diagnostic and imaging technologies. Escalon maintains corporate headquarters in Wayne, Pennsylvania, with operations located in Lake Success, New York; New Berlin, Wisconsin; and Stoneham, Massachusetts. The company pursues growth through development of new products, strategic partnerships, and acquisitions within the ophthalmic sector. As a medical device manufacturer, Escalon is subject to FDA regulation and operates under applicable quality and compliance standards for the medical device industry.

Caregility Corporation is an enterprise telehealth and virtual care platform provider serving healthcare systems, hospitals, and care facilities across inpatient, outpatient, and home settings. Founded in 2011, the company delivers the Caregility Connected Care™ Platform, a cloud-based ecosystem that integrates AI-powered clinical workflows, virtual nursing, bedside sensors, and secure video collaboration tools. The platform enables virtual care delivery across emergency departments, ICUs, operating rooms, observation units, behavioral health, neonatal care, and long-term care environments. With deployments in over 1,100 hospitals across 85+ health systems, Caregility facilitates more than 6 million virtual sessions annually. The platform addresses critical healthcare challenges including clinician shortages, geographic access barriers, and operational inefficiency through features such as real-time clinical collaboration, remote patient monitoring, automated workflow support, and integrated analytics. Caregility emphasizes 99.99% platform availability, HIPAA compliance, ISO 27001/27701 certification, and 24/7 expert support, positioning itself as a mission-critical infrastructure provider for hospital networks seeking to scale virtual care at enterprise scale.

BIOTRONIK is a multinational medical technology company headquartered in Berlin, Germany, specializing in implantable cardiac devices and neuromodulation systems. Founded in 1963, BIOTRONIK develops and manufactures advanced solutions for cardiac rhythm management, including pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. The company pioneered remote patient monitoring with BIOTRONIK Home Monitoring, the world's first telemedicine system for cardiac implant follow-up (launched 2000). Additional offerings include spinal cord stimulation systems for chronic pain management and electrophysiology tools for arrhythmia treatment. With manufacturing facilities in Germany, the United States, and Switzerland, R&D centers across North America, Europe, and Singapore, and presence in over 100 countries, BIOTRONIK has implanted more than 19 million devices globally. The company emphasizes digitally-driven patient monitoring, AI-enabled diagnostics, and remote care solutions to improve clinical outcomes and patient quality of life.

Healthcare MIT Services (HMS) is a medical technology company delivering AI-powered diagnostic imaging, intelligent patient monitoring, and connected care solutions. The company manufactures and distributes portable imaging systems, including low-dose fluoro-radiography and tabletop X-ray equipment designed for point-of-care, remote, and field deployment. Key product lines include contactless fall management and bedside monitoring systems utilizing AI-driven analysis without cameras or wearables; AI-enabled respiratory monitoring with noise-filtering capabilities; and clinical chemistry analyzers capable of running 16 tests in under 5 minutes with minimal blood samples (<90μL), ideal for remote and point-of-care settings. HMS also offers intelligent healthcare software solutions spanning smart ward and mobile nursing platforms, telehealth and remote care systems, and smart operating room integration. Medical supplies include certified PPE, mobile carts, and ready-to-deploy clinical kits. The company holds certifications including ISO 9001, ISO 13485, FDA clearance, EN 60601-1 medical device standard compliance, GMP, FCC, CUL, and CSA. HMS markets to hospitals, clinics, long-term care facilities, and field medical teams globally, with demonstrated presence at major medical conferences (HIMSS, RSNA, DMEA, AHCA/NCAL). The company emphasizes AI integration, radiation reduction, mobility, and safety across its product portfolio.

Vuzix Corporation is an optical technology company specializing in AI-powered smart glasses, waveguides, and augmented reality (AR) solutions for enterprise, industrial, medical, defense, security, and consumer markets. Founded in 1997 and headquartered in West Henrietta, New York, Vuzix designs and manufactures advanced wearable display systems including the M Series smart glasses, Vuzix Blade, Vuzix Shield, and Z100. The company provides waveguide optics, software solutions (including Mobilium logistics mobility software), and engineering services. With global operations in Rochester NY, Oxford UK, and Tokyo Japan, Vuzix serves multiple verticals through direct sales, resellers, and strategic partnerships. The company is ISO 9001:2015 certified and has over 25 years of experience in optical display solutions, positioning smart glasses as transformative tools for frontline workforce applications including telemedicine, remote assistance, warehouse operations, and healthcare delivery.

Hospicio La Paz is a leading hospice and palliative care provider in Puerto Rico, specializing in home-based end-of-life and comfort-focused medical services. The organization delivers comprehensive interdisciplinary care including physician oversight, nursing, medication management, respiratory therapy, and psychosocial support. Core service offerings include mechanical ventilation and BiPAP support (pioneering life-support equipment services with dedicated respiratory therapy staff), medication provision (5% copay or $5 minimum per medication), medical equipment and supplies, nutritional counseling, social work, spiritual care, and housekeeping assistance for activities of daily living. The company operates 24/7 physician and nursing availability. Telemedicine capability provides off-hours physician response to patient needs. Post-bereavement family support extends up to one year following patient death. Services are delivered in-home to emphasize comfort and dignity. The organization markets itself as a leader in palliative care services across Puerto Rico, with multiple operational locations. All care is designed as palliative comfort-focused rather than rehabilitative.

Firefly Global is a leading manufacturer of wireless portable digital magnifying cameras and video transmission systems for medical and veterinary professionals. The company specializes in high-definition digital imaging devices including wireless video otoscopes for ENT and audiology, endoscope camera systems with universal couplers for EMR integration, digital dermatoscopes with advanced polarizing optics, and telemedicine peripherals compatible with iPhone, iPad, Android, Windows, and Mac OS. Firefly's product portfolio also includes scientific and industrial digital microscopes with magnification up to 230x, veterinary examination tools, and precision accessories such as specula dispensers and TV adapters. Serving hospitals, clinics, medical schools, and veterinary practices across North America, Europe, and Asia, Firefly devices enable clinicians and specialists to capture, document, and stream high-quality live video for improved patient evaluation, education, and remote healthcare delivery.

Perigon Health 360 is a digital enterprise health platform specializing in remote patient monitoring (RPM), remote therapeutic monitoring (RTM), and chronic care management (CCM) services. The company develops proprietary medication adherence platforms and WiFi-connected medication dispensing devices that track real-time compliance data and integrate with healthcare provider systems through open APIs. Perigon Health 360's flagship offering, Medesto, is an enterprise drug and therapy monitoring platform that consolidates RPM and RTM services into a single portal, enabling healthcare providers and independent pharmacies to pursue reimbursement for monitoring services. The platform connects medication dispensing devices, physiological monitoring devices, and reimbursement tracking to simplify pharmacy compliance workflows. The company operates Perigon Pharmacy 360, an in-house pharmacy service covering all 50 states with specialty drugs and mail-order retail medications. Core capabilities include secure digital health data ecosystems, patient portal functionality, mobile app integration (Medesto app), and real-time alerting and reminder systems. The platform addresses medication non-adherence through multi-modal notifications and patient engagement tools. Perigon Health 360 holds URAC accreditation and is ACHC-certified, indicating compliance with industry standards for telehealth and pharmacy operations. The company serves healthcare providers, independent pharmacies, and patients with chronic conditions requiring ongoing medication management and monitoring.

Athena GTX manufactures compact, wireless patient monitoring systems designed for field and emergency medical scenarios. The company specializes in portable vital sign monitoring technology that enables real-time connectivity between patients and healthcare providers across distances. Their product suite is engineered for deployment in challenging environments including emergency departments, EMS transport, tactical medicine, battlefield triage, mass casualty incidents, search and rescue operations, and telemedicine applications. The systems are manufactured in-house in Iowa using proprietary medical and communication technology. Athena GTX serves emergency medical services, military/tactical medicine, public safety agencies, border security, and hospital emergency departments. The company positions its solutions for scenarios requiring rapid patient assessment, multi-patient monitoring, and remote clinical decision support. Applications span civilian emergency response, disaster management, infectious disease containment, and specialized rescue operations.

WoundMatrix is a cloud-based mobile wound documentation and telehealth platform designed for secure capture, measurement, and upload of wound images and clinical data at the point of care. The solution comprises a mobile application (tablet-based) paired with a Health-Enabled Cloud environment for centralized image reading, data analytics, and outcome tracking. Core capabilities include objective wound measurement technology (validated against Johns Hopkins clinical studies to reduce measurement variability), real-time data collection and analytics, customizable data fields for organizational standardization, and powerful outcome tracking reports for identifying trends and improving patient care quality. The platform is HIPAA-compliant and 21 CFR Part 11 validated, supporting both standalone cloud deployment and EHR integration. WoundMatrix serves private sector, governmental, and educational healthcare organizations, particularly those managing community wound care programs. The company partners with major health IT providers (Insight Enterprises) and integrates with leading UK electronic patient record systems (Rio EPR). WoundMatrix holds UKCA marking for UK market deployment and is accredited with the Association of British HealthTech Industries (ABHI) and the Professional Record Standards Body (PRSB), positioning it for adoption across NHS community services. The platform emphasizes ease of use, scalability to any organization size, and clinician-centric mobile workflows for wound documentation and remote care coordination.

LetsGetChecked Inc. is a direct-to-consumer and B2B healthcare company specializing in at-home health testing, telehealth consultations, and pharmacy services. The company manufactures and distributes at-home sample collection kits analyzed by its own CLIA-certified, CAP-accredited laboratory. Services include comprehensive health screening panels (cancer screening, women's health, men's health, infectious disease, biometric screening, and gap-in-care solutions), board-certified telehealth consultations via secure messaging, and affiliate pharmacy services for medication fulfillment and support. LetsGetChecked operates an integrated platform combining in-house manufacturing, laboratory analysis, clinical consultation, and pharmacy operations. The company serves both individual consumers and institutional clients including employers, health plans, health systems, and large organizations (Amazon, Denver Health, Humana, Berkshire Hathaway, University of Virginia, and others). Over 10 million kits have been used, with service delivery focused on accessibility, privacy, and convenience. The company is part of Fuze Health, a broader healthcare innovation platform. Regulatory compliance includes CLIA laboratory certification and CAP accreditation for clinical testing operations.

Actuvi is an award-winning remote therapeutic monitoring (RTM) and digital health delivery platform designed for clinical practices and healthcare organizations. The platform enables providers to deliver preventative and value-based care by integrating multiple apps, connected medical devices, and clinical assessments into a unified system. Actuvi aggregates patient physiological data, assessments, and interactions in one interface, eliminating traditional data silos. The platform includes a HIPAA-compliant web application, patient-facing mobile app (FDA-registered Software-as-Medical Device), and telehealth capabilities. Core features encompass remote patient monitoring, remote therapeutic monitoring (RTM), advanced primary care management, patient-practitioner messaging, PREMs and PROMs, eCOA/EDC for clinical trials, and custom assessment creation. The system integrates with EHRs, EMRs, Apple Health, Google Fit, and medical devices. Automation tracks, organizes, and assigns care activities to appropriate CPT codes for billing optimization. Actuvi serves diverse specialties including cardiology, concierge clinics, pain management, primary care, mental health, OB-GYN, oncology, orthopedic clinics, FQHCs, RHCs, and ABA clinics. The platform supports in-office, at-home, and rehabilitation care settings. Services include ongoing support, weekly program reporting, staff training, custom program configuration, and automated clinical notifications. The company has received multiple awards for remote therapeutic software and digital care solutions, and is trusted by major healthcare organizations.

Contact Health Inc operates a cloud-based remote patient monitoring (RPM) and virtual care engagement platform designed for healthcare providers to remotely monitor and interact with diverse patient populations. The platform addresses chronic disease management, behavioral and physical therapy, post-discharge care programs, and senior/disabled populations. The company's integrated solution comprises three core components: the Contact Health Tablet (patient-facing device with two-way video, biometric data transmission, health education, medication/appointment reminders, and secure messaging); the Contact Health Portal (provider-facing command center with risk stratification, triage tracking, vital sign graphing, medication adherence monitoring, non-responder tracking, and outcome reporting); and Contact Health Vitals (an array of medical devices including weight scales, blood pressure cuffs, pulse oximeters, glucose meters, and spirometers for automated biometric capture). The platform enables providers to capture vital signs data, interpret alerts through automated triage logic, intervene via video consultations, and monitor patient compliance with care plans. Key features include data analytics and trend reporting, population work lists, care calendars, and logistics/program support services. The company markets the solution to healthcare systems, accountable care organizations, behavioral health providers, and post-acute care settings seeking to improve remote monitoring capabilities and reduce hospital readmissions. The address on file matches the website, and the company can be reached at the provided contact information.

Remmie Health manufactures FDA-registered, portable digital otoscopes designed for home and telehealth-enabled ear, nose, and throat (ENT) examination and remote sharing with healthcare providers. The company's core product line includes the Remmie 3 and Remmie 4, intelligent otoscope cameras with high-definition (720p) imaging, wireless connectivity, real-time video streaming capabilities, and cloud-enabled mobile applications for iOS and Android devices. Remmie devices feature 3.9mm diameter lenses, adjustable brightness (5 levels), waterproof design, 2.4GHz Wi-Fi connectivity, and battery life supporting extended use. All devices ship with disposable specula, cleaning pads, charging accessories, and setup guidance. The Remmie App provides AI-guided image capture, local recording and saving of images and video, and live streaming to clinicians for remote diagnosis and intervention without requiring an internet connection for basic operation. The company targets parents, caregivers, and patients managing common ear and upper respiratory conditions (otitis media, otitis externa, sinusitis, pharyngitis, tonsillitis, strep throat, pink eye) while reducing costly emergency room and urgent care visits. Remmie devices are FDA Class 1 registered, CE marked, and cleared by Health Canada and Australian TGA. The company explicitly clarifies that Remmie devices are examination tools only and does not provide diagnostic, prescription, or telehealth services; users must consult independent healthcare providers for clinical care. Regulatory compliance and clinical validation are central to the company's positioning.

Heru, Inc. is an ophthalmology and eye care technology company founded on clinical research from the University of Miami's Bascom Palmer Eye Institute, the nation's leading eye hospital. The company develops wearable headset-based vision testing systems and digital eye care platforms, with a primary focus on visual field testing, glaucoma screening, and tele-optometry solutions. Heru's flagship product, Heru Prime, is a next-generation multimodal platform designed to standardize patient pretesting and elevate clinical workflows. The company also offers EyeStream™ technology, a pretesting solution that reduces manual variability in patient assessment. Heru's systems are designed for optometry practices, ophthalmology clinics, and telehealth platforms seeking to improve patient throughput and diagnostic accuracy. The company has received recognition as a CES 2023 Innovation Awards Honoree in the Virtual and Augmented Reality category for two consecutive years, validating the clinical efficacy and innovation of its wearable headset approach. Heru conducts clinical validation studies comparing its wearable-based visual field measurements against standard automated perimetry, demonstrating comparable accuracy in a more accessible format. The platform supports tele-optometry strategies, allowing remote eye care delivery with standardized pretesting protocols.

Virtual Radiologic Corporation (vRad) is a distributed radiology services provider delivering 24/7 teleradiology coverage, AI-assisted diagnostic support, and integrated radiology platform solutions. Founded in 2001, vRad operates as a remote radiology network serving 140+ communities with a focus on subspecialized services, particularly breast imaging including telemammography screening, diagnostics, and compliance support. The company has served over 115.9 million patients. vRad's core offerings include: (1) Teleradiology Services—remote radiology interpretation with rapid turnaround for critical patients; (2) vRad Platform—a unified radiology information system (RIS) and PACS ecosystem designed to reduce administrative burden and integrate disconnected radiology workflows; and (3) Radiologist staffing and career opportunities with flexible scheduling. The platform incorporates 25+ proprietary AI models to enhance diagnostic speed and accuracy, achieving 99.87% accuracy with 88% fewer errors compared to published benchmarks. The company employs over 140 subspecialist radiologists and maintains focus on early breast cancer detection through telemammography services. vRad's technology stack is built by radiologists and engineers to optimize the radiology workflow and practitioner experience. The platform includes integrated reporting, quality assurance tools, and subspecialty decision-support capabilities. vRad serves hospitals, imaging centers, and multi-specialty practices seeking outsourced teleradiology coverage or platform modernization. High radiologist satisfaction metrics (98% would remain with vRad; 96% proud to be associated) reflect competitive compensation and schedule flexibility. The company operates nationwide with centralized remote reading infrastructure.

NeuroVision Imaging, Inc. is a digital health and diagnostic imaging company focused on neurology and cognitive health. The company operates two primary business lines: BrainHealth, a comprehensive telehealth platform for cognitive neurology that addresses diagnostic wait times through patient screening, triage, and managed care workflows; and Afina, a proprietary retinal imaging platform with cloud-based AI software designed to identify amyloid signatures in the retina as indicators of Alzheimer's disease and Cerebral Amyloid Angiopathy (CAA). BrainHealth offers neurologist-designed preventative neurology strategies, brain health education (covering nutrition, sleep, exercise, and mindfulness), lifestyle change coaching via telehealth, APOE genetic testing, biomarker testing, and clinical trial information. Afina leverages advanced imaging and AI analytics to support prediction of CAA and amyloid-related imaging abnormalities (ARIA), the significant side effect associated with emerging Alzheimer's treatments. The platform combines diagnostic innovation with clinical validation through ongoing groundbreaking studies. NeuroVision targets healthcare providers, health systems, and patients seeking accessible, evidence-based neurology diagnostics and preventative care at scale.

Remote Patient Devices, LLC is a US-based remote patient monitoring (RPM) provider serving medical practices, healthcare facilities, and chronic disease management programs. The company develops and operates a cloud-based RPM platform enabling patients to transmit vital signs—blood pressure, glucose levels, and weight—from home or office settings for real-time clinical review. The platform integrates with existing EHR systems, supports iOS and Android mobile applications, and includes automated time tracking, customizable clinical alerts, and EMR interoperability. Remote Patient Devices serves solo practices, group practices, and larger healthcare systems seeking to expand preventive and chronic care management outside traditional clinical settings. The company handles end-to-end RPM implementation including patient eligibility verification, care plan development, medical billing and coding, and compliance with current healthcare regulations (MIPS quality measures, value-based care models). The platform emphasizes patient engagement, clinical actionability of real-time data, and revenue optimization through accurate remote patient monitoring billing. Core use cases include hypertension management, diabetes monitoring, and post-acute care transitions. Remote Patient Devices markets RPM as a tool for reducing hospital readmissions, improving MIPS scores, and generating $100,000–$150,000 annual revenue per 100 monitored patients for practices. The company provides practitioner training, ongoing clinical support, and billing assistance to ensure sustainable adoption.

Buoy Health is an AI-powered digital health platform that provides symptom assessment, clinical decision support, and care navigation for consumers. The platform combines machine learning algorithms with clinician-reviewed medical content to help users identify potential health conditions based on self-reported symptoms and receive personalized guidance on appropriate care pathways. Founded by physicians and data scientists at Harvard Innovation Labs, Buoy integrates artificial intelligence-driven triage with expert-curated health information, enabling users to make informed decisions about seeking professional medical care. The company serves individuals seeking accessible, evidence-based health guidance and care coordination outside traditional clinical settings.

GlobalMed Holdings is a leading virtual health software and hardware platform company delivering enterprise telemedicine solutions for 20+ years. The company provides eNcounter®, a comprehensive all-in-one virtual care platform supporting 55+ clinical modalities with multi-modal device integration, AI-powered triage, and true EHR/EMR interoperability. GlobalMed's hardware ecosystem includes FDA-cleared diagnostic devices—TotalExam® 3.2 Camera for high-definition remote examinations, TotalECG® for cardiac monitoring, TotalVitals® for continuous vital signs capture, and ClearProbe® ultrasound system—enabling comprehensive head-to-toe remote physical exams with diagnostic-quality imaging and real-time data streaming. The company also manufactures portable clinical delivery stations (ClinicalAccess® Pro Connect, Transportable Exam Backpack) certified to ISO 13485 for hospital-grade care in austere, remote, and emergency environments. Additional offerings include GlobalMed Wellness employee mental health apps (Moodhacker®, Love Every Day®, Family Huddle®) developed with NIH grant funding. The platform is deployed across federal agencies (DoD, VA, DHS, Department of Justice), rural health systems, correctional facilities, large health systems, and international markets across 60+ countries, supporting 100 million+ virtual healthcare visits. Certifications include SOC 2 Type II, HIPAA compliance, FDA 510(k) clearances for medical devices, ISO 13485, and Authority to Operate (ATO) on DoD networks.

Smartsound Corporation is a Seoul-based medical technology company specializing in AI-powered sound-based diagnostic solutions. Founded in 2011, the company has developed proprietary edge artificial intelligence technology that analyzes heart and lung sounds for disease diagnosis. Since 2021, Smartsound has collaborated with 12 leading Korean university hospitals to collect and analyze clinical data, securing AI diagnostic technologies capable of identifying 5 types of lung diseases and 5 types of heart diseases. The company offers a comprehensive portfolio of AI-enabled stethoscope products—including the SKEEPER R1 (hospital-grade), SKEEPER H1 (telemedicine/homecare), SKEEPER P1 (wearable patch for continuous monitoring), SM-300 (non-face-to-face telemedicine), and WITH A PET (veterinary cardiac assessment)—all featuring hardware-embedded AI, cloud data storage, Bluetooth connectivity, and telemedicine integration. Products support diagnosis, monitoring, and early detection of respiratory infections and cardiac conditions across clinical, home healthcare, and veterinary markets.

Solaborate Inc. develops hellocare, an integrated end-to-end telehealth and virtual healthcare delivery platform combining software, hardware, and artificial intelligence. The platform serves hospitals, home care, and primary care settings, enabling clinicians to deliver remote patient care through multiple modalities: virtual patient observation (up to 16 rooms monitored simultaneously), telehealth consultations, remote patient monitoring (RPM), and digital clinic services. Core capabilities include real-time audio/video communication, secure messaging, EHR integration, dynamic workflow management, and AI-driven alerting for fall detection and patient behavior monitoring. The company supplies integrated telemedicine carts (mobile hardware and software solutions), remote examination kits that enable physicians to assess vital signs and conduct clinical examinations from patient homes, and communication tools linking clinicians, nurses, and healthcare teams. The platform processes continuous patient observation data, captures health metrics from connected medical devices, and uses edge-based AI algorithms to generate clinical alerts while maintaining patient privacy. Solaborate maintains HIPAA compliance, HITRUST certification, SOC 2 attestation (AICPA), and CE marking. The platform is used by major healthcare systems including Amwell, Northwell Health, and Swiss healthcare organizations. Intended for B2B deployment in hospital systems, urgent care, home health agencies, and telemedicine networks requiring turnkey virtual care delivery infrastructure.

Cloud DX Inc. is a Canadian healthcare technology company specializing in remote patient monitoring (RPM) hardware, software, and digital health services. The company develops the FDA-registered, Health Canada-licensed Connected Health™ platform, which enables comprehensive vital sign monitoring and clinical engagement for chronic disease management, post-surgical care, palliative care, and transitional care. Cloud DX's integrated solution includes wireless vital sign devices (blood pressure monitors, weight scales, pulse oximeters), a clinician dashboard for real-time patient data review, a mobile app for patient engagement, and telemedicine capabilities powered by Zoom or Teladoc. The platform is currently deployed across 12 clinical use cases including COPD, heart failure, diabetes, post-surgical monitoring, and complex pediatric home care. Cloud DX operates a Virtual Care as a Platform (VCaaP) model with demonstrated patient satisfaction of 89–100% and peer-reviewed clinical evidence of improved outcomes, reduced ER visits, and decreased hospital admissions.

Aerotel Medical Systems is a global provider of remote patient monitoring and telemedicine solutions specializing in 12-lead ECG cardiac monitoring. The company manufactures portable, user-friendly ECG devices combined with cloud-based call center software and transtelephonic transmission capabilities for real-time patient data transfer via Internet, cellular, or telephone networks. Aerotel's product portfolio includes the HeartView 12L (professional handheld 12-lead ECG), HeartView P12/8i (Bluetooth-enabled personal ECG recorder), and HeartView P12/8 Mobile (home monitoring device with cellular modem and voice assistance). The company serves ambulance services, hospitals, telemedicine providers, and home monitoring programs globally. Aerotel's HeartView P12/8 has demonstrated clinical efficacy in published peer-reviewed research showing reduced in-hospital mortality when deployed by ambulance services. The company has successfully completed large-scale national projects, including equipping Hungary's national ambulance service (OMSZ) with ECG monitoring capabilities. Products incorporate voice-guided protocols to enable non-medical personnel to obtain hospital-grade ECG recordings. The company emphasizes one-stop integration support from solution design through implementation and ongoing operations. Founded in 1998, Aerotel maintains global headquarters in Holon, Israel, with international distribution through medical device distributors and service partners.

Eyoto Group Limited manufactures Aetheia, a fully remote, automation-powered 4K digital slit lamp system designed for tele-optometry and remote eye examinations. The platform enables optometrists and ophthalmologists to deliver expert eye care from any location without patient travel, addressing clinician shortages and enabling clinic expansion across multiple sites. Aetheia features 120° arm rotation, 4K imaging with 25x zoom, and integrated automation capabilities (Auto-Optometry™ and Auto-Assist™) to streamline exam workflows. The system supports both remote control operation by licensed clinicians and fully autonomous examination modes, significantly increasing patient throughput without requiring additional headcount. Installation is scalable to any clinic setting, with onsite training and post-sale support included. The company has secured major deployments, including a nationwide rollout across SpaMedica's hospital network in the UK (announced December 2025). The Aetheia platform targets ophthalmology services facing resource constraints and high-volume optometry clinics seeking to optimize operational efficiency while maintaining diagnostic precision.

EyeQue Corporation is a FDA-registered health technology company specializing in smartphone-powered at-home vision testing solutions. The company develops clinically validated devices and AI-based applications that enable users to measure visual acuity, pupillary distance, and refractive error from home, facilitating prescription updates and vision tracking over time. Primary products include VERAI (complete AI vision solution), Insight Lite (pocket-sized screening device), PDCheck/PDCheckAR (pupillary distance measurement), myReaderNumber (reading glass prescription), Rx Renewal (prescription renewal service), and Try-On Glasses (virtual frame fitting). EyeQue's platform supports integration with eye care professionals for telemedicine consultations, interim monitoring, and online glasses purchasing. The solution addresses accessibility gaps for rural populations and patients with mobility constraints, with over 100,000 satisfied customers and clinical endorsement from optometrists.

Mindset Medical is a digital health technology company that delivers an intelligent virtual health platform enabling intake, patient assessments, triage, and virtual exams through smartphone-based contactless video vital sign measurement. The platform uses patented remote photoplethysmography (rPPG) technology to transform standard device cameras into non-contact vital sign sensors, measuring heart rate, respiratory rate, and other physiological parameters without requiring traditional measurement devices or wearables. The solution includes real-time remote patient monitoring, precision health analytics, and API integration capabilities for seamless deployment across digital health ecosystems. Core features include edge-processing for privacy (video analysis occurs on-device with no transmission), end-to-end encryption, and FDA-cleared respiratory rate measurement functionality. Ideal for telehealth platforms, chronic disease management, post-acute care coordination, and integrated care delivery requiring continuous remote patient monitoring without hardware burden.

JEDMED Instrument Company is a 100% employee-owned medical device manufacturer founded in 1978 and based in St. Louis, Missouri. The company specializes in high-quality surgical instruments and visualization equipment serving ENT, ophthalmology, dental, audiology, and telemedicine specialties. JEDMED offers a comprehensive portfolio including German-crafted surgical instruments, endoscopic video systems, examination and surgical chairs, microscopes, and specialized equipment such as the FDA-approved OMNISteth™ digital stethoscope for telemedicine applications. The company's product range encompasses endoscopic visualization systems, otoscopy equipment, stroboscopy systems, portable video systems, and exam room furniture. With approximately 35 employees, JEDMED maintains a strong commitment to customer satisfaction and professional support, distributing products through authorized partners including Melling Medical for federal healthcare systems. The company's offerings are particularly valued in clinical settings requiring precision visualization, diagnostic support, and ergonomic examination infrastructure.

PathPresenter is an enterprise-grade digital pathology image management and workflow platform founded in 2017 by Dr. Rajendra Singh, a dermatopathologist and digital pathology pioneer. The platform serves pathologists and medical institutions with FDA 510(k)-cleared and CE-IVDR certified clinical viewers for primary diagnosis and consultations. PathPresenter offers comprehensive modules including clinical care, enterprise education, biorepository management for research data, and remote consultation capabilities via ConsultConnect. The system emphasizes vendor-agnostic interoperability, supporting any scanner, storage platform, laboratory information system (LIS), and third-party AI models. Key features include optimized pathologist workflows, voice control integration, powerful slide administration, and seamless integration across institutional systems. With over 50,000 users across 172 countries and adoption by more than 50 top-tier hospitals, laboratories, and pharmaceutical companies, PathPresenter combines clinical performance with AI readiness, enterprise integration, and education leadership. The platform powers the College of American Pathologists' AI Studio, enabling testing of cutting-edge AI tools in realistic scenarios with whole slide images.

DrKumo is a Service-Disabled Veteran-owned digital health technology platform specializing in Remote Patient Monitoring (RPM) and chronic care management. The company delivers AI/ML-driven solutions that enable real-time health data transmission from patients' homes to clinical care teams, facilitating proactive interventions and early risk detection. DrKumo's platform integrates wireless medical sensors, mobile data acquisition, and intelligent cloud services to support evidence-based Disease Management Protocols for chronic conditions including diabetes, hypertension, COPD, and heart failure. The platform operates on military-grade cybersecurity infrastructure meeting HIPAA, FIPS, and NIST standards. DrKumo provides turnkey deployment with no upfront cost to providers and focuses on expanding healthcare access to rural and underserved communities, including Native American populations and veterans. The solution is designed to reduce hospital readmissions, improve patient satisfaction, increase provider reimbursement, and streamline administrative workflows across private practices, FQHCs, RHCs, and health systems.

EBM Technologies is a leading medical IT solutions provider specializing in Picture Archiving and Communication Systems (PACS), Electronic Medical Records (EMR), and Personal Health Records (PHR). Founded in 1988 in Taiwan, the company serves over 3,500 hospitals across Asia, North America, and the Middle East. EBM's product portfolio includes Enterprise PACS systems (SoliPACS®, Pangea® suite for Radiology/Dental/Mammography), mobile PACS applications (MobiPACS®), telemedicine platforms, and eHealth solutions. The company emphasizes interoperability, allowing integration across diverse healthcare infrastructure, and has shifted focus toward mobile medical applications and AI-integrated diagnostic solutions. With 150 employees, EBM delivers cost-effective, scalable, and customizable software platforms designed for efficient medical data management and enhanced patient care delivery.

Alliance Tech Medical manufactures and distributes a comprehensive line of respiratory disease management products for hospitals, surgery centers, physician offices, clinics, home care, and pharmacies. Their portfolio includes spirometers (MIR, ERT SpiroSphere, Micro Direct models), peak flow meters, inhalation training devices (In-Check DIAL, Trainhaler, AIM), nebulizers (PARI, SALTER), pulmonary function filters, CPAP cleaning systems (Lumin), respiratory muscle trainers (The Breather), and high-level disinfectants (Revital-Ox RESERT). They also distribute products from Clement Clarke International, Nasiff, and Cetylite Industries. Alliance Tech Medical offers OEM customization and branding services for medical devices, with a focus on affordable, practical solutions for respiratory care adherence and compliance management.

IONIC Health is a health-tech company specializing in automation, integration, and remote operation technologies for diagnostic medicine, particularly medical imaging. Founded in 2019 with headquarters in São José dos Campos, Brazil, and offices in Cleveland, Ohio and Portugal, IONIC Health serves over 90 B2B clients globally, including major diagnostic centers and hospital networks. The company provides comprehensive software and digital solutions designed to improve efficiency, safety, and accessibility in diagnostic imaging workflows. Key offerings include remote teleoperation platforms for imaging devices (MRI, CT, ultrasound), real-time equipment monitoring and analytics, AI-powered structured radiology reporting with speech recognition, and end-to-end integration solutions. IONIC Health leverages advanced technologies including artificial intelligence, machine learning, big data analytics, and voice recognition to enable remote scanning, automated workflows, and intelligent decision support. With CE Mark approval and ISO/IEC 27001 certification, IONIC Health has demonstrated measurable impact: over 1 million exams facilitated, 1 million+ medical reports issued, 300+ devices under teleoperation, and documented customer savings exceeding $20 million. The company serves a diverse network of over 2,500 physicians and continues expanding across Latin America, Europe, and North America.

YIWEI Medical Technology (Dr. Brain) is an AI-powered diagnostic platform specializing in central nervous system (CNS) disease detection and brain health management. Founded in 2017 in Shenzhen, the company leverages a comprehensive Chinese brain imaging database, cloud computing, and advanced AI algorithms to deliver intelligent imaging analysis and diagnostic support across multiple neurological conditions including Alzheimer's disease, mild cognitive impairment, Parkinson's disease, stroke, brain tumors, and autism spectrum disorders. The platform comprises four primary solutions: Dr. BrainCloud (intelligent imaging diagnostic platform for CNS disease assessment), Dr. Brain Tele (cloud-based tele-imaging platform supporting remote consultation and expert review across primary care facilities), Dr. Brain Pharm (neuropharmacological efficacy evaluation system for clinical drug development and R&D), and Dr. Brain Health (comprehensive brain health management services including AI-based whole-brain examination, disease prevention, VR-based cognitive rehabilitation training, and patient counseling). The company integrates quantitative structural brain analysis, personalized VR-based cognitive assessment using eye-tracking technology, and immersive rehabilitation training protocols to improve diagnostic accuracy and enable early intervention.

HealthArc is a comprehensive digital health platform specializing in remote patient monitoring (RPM), chronic care management (CCM), and care coordination software for healthcare providers. The platform integrates with over 40 compatible medical devices (blood pressure monitors, glucometers, pulse oximeters, weight scales, spirometers, continuous glucose monitors, thermometers, and medication adherence trackers) to enable real-time vital sign monitoring and patient data collection. HealthArc's unified care platform features AI-driven clinical pathways, automated workflow management, and intelligent patient communication via SMS and phone escalation. The software supports multiple CMS-compliant care programs including Remote Patient Monitoring, Chronic Care Management, Principal Care Management, Remote Therapeutic Monitoring, Transitional Care Management, Medication Therapy Management, Behavioral Health Integration, and Advanced Primary Care Management. The platform automates billing documentation and claims submission across these programs, integrates with existing EHR systems, and includes specialized clinical support services with enrollment specialists, RNs, LPNs, and medical assistants. HealthArc serves hospitals, primary care practices, virtual care delivery companies, and managed healthcare organizations, with current deployment across 40+ states serving 750+ providers and 65,000+ patients. The company prioritizes HIPAA compliance, SOC2 certification, and FDA-approved device integration.

ChatRx is an FDA-approved, AI-powered asynchronous telemedicine platform specializing in diagnosis and treatment of 39 common acute infections. The platform combines proprietary AI-assisted symptom assessment with physician review and oversight to deliver care 24/7 without requiring video appointments or scheduled consultations. Available in Indiana, Illinois, and Michigan, ChatRx addresses healthcare access gaps for uninsured patients, rural communities, shift workers, and others facing barriers to traditional urgent care. The service operates on a flat-fee model ($25 per consultation, $10 for work/school notes) and provides treatment plans with prescriptions when medically appropriate. The platform achieves >90% diagnostic accuracy and includes integration with pharmacy networks for prescription delivery.

Eko Health is a digital health company specializing in AI-powered cardiac and pulmonary disease detection and monitoring. The company manufactures FDA-cleared digital stethoscopes and ECG devices that combine high-fidelity audio capture with real-time artificial intelligence algorithms to detect heart murmurs, atrial fibrillation, and reduced ejection fraction. Eko's product ecosystem includes the CORE 500™ Digital Stethoscope with advanced audio processing and noise cancellation, the CORE™ Digital Stethoscope (co-branded with 3M as Littmann® CORE), and the SENSORA® platform for health system integration. The company also offers Eko AI Analysis software for clinical decision support and Eko Telehealth for virtual exam capabilities, deployed in over 800 U.S. hospitals. With more than 700,000 devices sold globally, Eko operates the largest connected digital stethoscope network. The platform is clinically validated across 70+ peer-reviewed publications and holds 9 FDA clearances, with CMS reimbursement established for hospital-based outpatient cardiac screening.

Amalgam Rx is a regulated digital health company specializing in Software as a Medical Device (SaMD) development. Founded in 2016 and based in Wilmington, Delaware, the company develops AI-powered, modular SaaS platforms that integrate seamlessly with electronic health records (EHR) to enhance clinical decision-making across chronic care ecosystems. The company's Medical-Grade AI™ technology supports patient identification for clinical trials, clinical decision support, digital therapeutics (DTx), caregiver engagement, and wearable device integration. Amalgam Rx's platform has facilitated over 70 million clinical decisions and currently supports nearly 10 million patients across four continents with regulatory clearance. The company partners with life sciences organizations, health plans, and healthcare providers to deliver point-of-care solutions including care guidelines, financial assistance programs, and companion products. With demonstrated FDA expertise and Manufacturer of Record (MOR) designation, Amalgam Rx emphasizes regulatory compliance, quality management systems, and global scalability across multiple markets.

CEIBA Health Technologies is an AI-powered healthcare technology platform specializing in virtual clinical care and medical device connectivity solutions. The company delivers an integrated Enterprise Suite with four core capabilities: (1) IoMT Interoperability—featuring a plug-and-play IoMT Box with 1,000+ pre-installed device drivers supporting 20+ EHR integrations; (2) Continuous Monitoring—delivering real-time telemetry dashboards for patient monitors, ventilators, infusion pumps, blood gas analyzers, and EEG machines across ICU, med-surge, LTACH, and SNF settings; (3) Decision Support & Workflow—providing actionable clinical insights and operational dashboards; and (4) Virtual Clinical Care—a telehealth platform enabling multi-specialty consultations, remote rounding, and acute care at home. CEIBA's protocol-agnostic architecture supports HL7, FHIR, JSON, and XML with enterprise-grade security, encrypted data transfer, and full mobile functionality. The platform is designed for rapid deployment (days vs. months) and serves hospitals and health systems in the US and internationally.

ASCEND Cardiovascular is a specialized cardiovascular IT solutions provider headquartered in Springfield, Illinois. Founded in 1995, the company develops enterprise-grade structured reporting and workflow software designed exclusively for cardiology departments and health systems. The ASCEND CV portfolio delivers multimodality structured reporting capabilities that integrate diagnostic, procedural, and reporting workflows into a unified cardiovascular ecosystem. Core offerings include ASCEND CV (multimodality reporting software), ASCEND InView (zero-footprint DICOM viewer), Gen3Echo (AI-driven echocardiography reporting), ASCEND Analytics (open-schema data warehouse), and Catalyst LIVE (telepresence collaboration platform). The company provides vendor-agnostic solutions with device interfaces, clinical decision support, and implementation services. ASCEND serves leading North American health systems and hospitals, with specialized solutions for pediatric cardiology, congenital heart disease, and non-invasive cardiac imaging. The platform integrates seamlessly with major EHR/HIS systems and medical device manufacturers including Epic, Cerner, GE Healthcare, Philips, and AGFA Healthcare.

Foresight Imaging is an OEM manufacturer of high-performance video capture boards and PACS connectivity solutions for medical and defense imaging applications. ISO 13485 certified, the company has produced over 100,000 imaging boards in use at elite medical centers worldwide. Foresight Imaging specializes in high-accuracy video streamers and frame grabbers supporting multiple video signal types (HDMI, DVI, SDI, monochrome, RGB, analog, standard and non-standard formats) with sustained transfer rates up to 1.3 GB/second and advanced signal processing (±0.5 ns pixel jitter, 59 dB signal-to-noise ratio, 10-bit A/D conversion). The company's TIMS platform is a 510(k)-accredited analog-to-DICOM workstation solution combining image acquisition software with telemedicine capabilities for remote diagnostics. Applications include surgical recording, angiography, OCT, ultrasound imaging, and specialized medical visualization. Foresight provides comprehensive OEM support including software development kits (C libraries, DirectShow drivers, example programs in .NET, C++, Linux), technical engineering support during development, and automated configuration tools.